TREATMENT OF OPHTHALMOLOGIC DISEASES
The current invention relates to the use of antibodies which bind to VEGF and ANG2 for the treatment of ophthalmologic diseases.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
28.08.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The current invention relates to the use of antibodies which bind to VEGF and ANG2 for the treatment of ophthalmologic diseases. |
---|---|
Bibliography: | Application Number: SG20201106712X |